Expanding upon our initial discovery that tetrandrine amplifies MHC-I-mediated antigen presentation in melanoma cells, we delved into its consequential effects on CD8+ T cell recognition and cytotoxic activity against these cancer cells (Fig. 2). This evidence concerns the gene CD8A and melanoma.